Acute myeloid leukaemia refractory

• Multi-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS Pending
  2025-523396-38-00 9 "Relapse or refractory (r/r) acute myeloid leukaemia (AML) an"
• A trial to learn how safe AZD3632 is, how well it works, and how it moves throughout the body over time in adults with acute leukemia and my … Recruiting
  2025-521299-76-00 7 2025-12-18 "Relapsed or refractory acute leukaemia or Myelodysplastic Sy"
• A study to evaluate S227928 as a Single Agent and in Combination with Venetoclax in Patients with R/R AML, MDS/AML, or CMML Ended
  2024-514356-33-00 7 2025-02-11 ""Patients with Relapsed/Refractory (R/R) Acute Myeloid Leuke"
• APTIVATE Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients with … Ended
  2023-503244-14-00 7 2023-08-11 "Relapsed or Refractory Acute Myeloid Leukemia (AML)"
• First-in-human study of SAR443579 infusion in male and female children and adult participants with relapsed or refractory acute myeloid leuk … Ended
  2023-508357-58-00 7 2022-07-04 "Acute lymphocytic leukaemia- Acute myeloid leukaemia refract"
• A Dose Finding Phase 1 Study of CC-96191 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia Ended
  2022-500573-13-00 1 2021-07-06 "Relapsed or Refractory Acute Myeloid Leukemia"

Showing 1–6 of 6 trials